Cargando…
Sorafenib prevents the proliferation and induces the apoptosis of liver cancer cells by regulating autophagy and hypoxia-inducible factor-1
Sorafenib has been approved as a systemic drug for advanced liver cancer; however, the underlying mechanisms remain unclear. The present study aimed to investigate the effects of sorafenib on the proliferation, autophagy and apoptosis of HepG2 cells under hypoxia. Briefly, reverse transcription-quan...
Autores principales: | Yang, Qingzhuang, Gao, Lianghui, Huang, Xiaolong, Weng, Jie, Chen, Youke, Lin, Shibu, Yin, Qiushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311259/ https://www.ncbi.nlm.nih.gov/pubmed/34345262 http://dx.doi.org/10.3892/etm.2021.10412 |
Ejemplares similares
-
LncRNA model predicts liver cancer drug resistance and validate in vitro experiments
por: Yin, Qiushi, et al.
Publicado: (2023) -
Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
por: Li, Jun, et al.
Publicado: (2018) -
Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma
por: Liang, Chao, et al.
Publicado: (2020) -
Melatonin prevents chronic intermittent hypoxia-induced injury by inducing sirtuin 1-mediated autophagy in steatotic liver of mice
por: Ren, Jie, et al.
Publicado: (2018) -
Correction to: Melatonin prevents chronic intermittent hypoxia-induced injury by inducing sirtuin 1-mediated autophagy in steatotic liver of mice
por: Ren, Jie, et al.
Publicado: (2022)